Clinical Trial Update: Effect of High-Dose Quadrivalent Influenza Vaccine (Efluelda®) Versus Standard-Dose (QIV-SD), in Subjects 65 Years of Age and Older on Innate Immunity, Including Gene Expression [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing high-dose quadrivalent influenza vaccine Efluelda with standard-dose QIV-SD in adults 65+ assessing innate immunity and gene expressio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Influenza Infection
• Vaccine Reactions

Drugs mentioned

• Efluelda
• QIV-SD (Standard-dose quadrivalent inactivated influenza vaccine)

Snippet

Sponsor: Centre Hospitalier Annecy Genevois | Conditions: Vaccine Reaction | Phase 4 | Status: COMPLETED